JP2008214331A - ピンポイント注射りょう法 - Google Patents

ピンポイント注射りょう法 Download PDF

Info

Publication number
JP2008214331A
JP2008214331A JP2007107581A JP2007107581A JP2008214331A JP 2008214331 A JP2008214331 A JP 2008214331A JP 2007107581 A JP2007107581 A JP 2007107581A JP 2007107581 A JP2007107581 A JP 2007107581A JP 2008214331 A JP2008214331 A JP 2008214331A
Authority
JP
Japan
Prior art keywords
cancer
anticancer agent
therapeutic method
dose
pinpoint
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007107581A
Other languages
English (en)
Inventor
Hirohiko Iida
裕彦 飯田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2007107581A priority Critical patent/JP2008214331A/ja
Publication of JP2008214331A publication Critical patent/JP2008214331A/ja
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

【課題】従来のがん治りょうでは、こうがん剤をてんてきで、体全身に投与していたため、薬の量も多く、副作用も多かった。
【解決手段】こうがん剤を直接、がんの病すに注射することによって、こうがん剤の量が少なくてすみ、副作用も少ない。また、直接、がんの病すに注射するので、てきかくに、こうがん剤の作用を打ち出すことができる。
【選択図】図１

Description

医りょうの治りょうに関する注射りょう法。
こと、がん治りょうには注射で直接、がんの病すに、こうがん剤を打ちこむ事がないため、こうがん剤が大量にいるため、副作用が多かった。
てんてきで、体全体にこうがん剤を投与するので副作用が多い。
直接、がんの病すにこうがん剤を打ちこむ。
▲１▼直接、がんの病すにこうがん剤を打ちこむので、薬の量が少なく、副作用が、少なくてすむ。▲２▼がんに直接注射なので、こうか的である。▲３▼まっきがんに効かてき。
医りょう機かんにしてもらう。（医者）
がんの病すに直接注射する。

Claims (1)

  1. がんの病すに直接こうがん剤を注射する。
JP2007107581A 2007-03-07 2007-03-07 ピンポイント注射りょう法 Pending JP2008214331A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007107581A JP2008214331A (ja) 2007-03-07 2007-03-07 ピンポイント注射りょう法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007107581A JP2008214331A (ja) 2007-03-07 2007-03-07 ピンポイント注射りょう法

Publications (1)

Publication Number Publication Date
JP2008214331A true JP2008214331A (ja) 2008-09-18

Family

ID=39834803

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007107581A Pending JP2008214331A (ja) 2007-03-07 2007-03-07 ピンポイント注射りょう法

Country Status (1)

Country Link
JP (1) JP2008214331A (ja)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006083979A2 (en) * 2005-02-02 2006-08-10 Nexgenix Pharmaceuticals, L.L.C. Local treatment of neurofibromas

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006083979A2 (en) * 2005-02-02 2006-08-10 Nexgenix Pharmaceuticals, L.L.C. Local treatment of neurofibromas

Similar Documents

Publication Publication Date Title
RU2470016C2 (ru) Производное бипиразола
MX2009010000A (es) Dispositivo para el suministro de farmaco.
EA200501420A1 (ru) Устройство доставки для лекарственной и клеточной терапии
MX2009005339A (es) Suspensiones analgesicas de liberacion modificada.
JP2006501240A5 (ja)
MX2009013574A (es) Formas de dosificacion solidas o semisolidas de liberacion modificada.
JP2014528901A5 (ja)
RU2007132181A (ru) ПРОТИВОРАКОВОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ α,α,α-ТРИФТОРТИМИДИН И ИНГИБИТОР ТИМИДИНФОСФОРИЛАЗЫ
BRPI0510895A (pt) formulação farmacêutica de 10-propargila-10-deazaaminopterina para tratamento de linfoma de célula t
BRPI0708640A8 (pt) composição farmacêutica, e, métodos para tratar um paciente com dor de cabeça de enxaqueca, para tratar um paciente com dor e para tratar um paciente com enxaqueca
WO2007098479A3 (en) Localized insulin delivery for bone healing
EP2216024A3 (en) Use of Ranolazine for the treatment of cardiovascular diseases
JP2015524444A5 (ja)
IL196425A (en) Dosage unit for oral administration containing ibuprofen and pamotidine
JP2013541583A5 (ja)
JP2017508749A5 (ja)
RU2014150942A (ru) Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона
TW200628182A (en) Injection device for administering a medication liquid
MX2013012206A (es) Metodo para producir substancias con gas sobresaturado,dispositivo de suministro transdermico de las mismas, y usos de las mismas.
NZ591408A (en) Paracetamol and Calcium carbonate composition
BRPI0607172A2 (pt) método para a ministração de pelo menos uma substáncia farmaceuticamente ativa a um paciente, combinação de medicamentos e uso de pelo menos uma substáncia farmaceuticamente ativa para a fabricação de uma combinação de medicamentos
MX2013012204A (es) Metodo para producir substancias con gas sobresaturado, dispositivo de suministro transdermico de las mismas, y usos de las mismas.
JP2008214331A (ja) ピンポイント注射りょう法
MX2013012205A (es) Metodo para producir substancias con gas sobresaturado, dispositivo de suministro transdermico de las mismas, y usos de las mismas.
MX2010006310A (es) O-desmetil-venlafaxina para el tratamiento de transtorno depresivo mayor.

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080801

A131 Notification of reasons for refusal

Effective date: 20110426

Free format text: JAPANESE INTERMEDIATE CODE: A131

A02 Decision of refusal

Effective date: 20120124

Free format text: JAPANESE INTERMEDIATE CODE: A02